<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=136546"><dc:title>COVID-19 vaccines safety tracking (CoVaST)</dc:title><dc:creator>Riad,	Abanoub	(Avtor)
	</dc:creator><dc:creator>Marc,	Janja	(Avtor)
	</dc:creator><dc:creator>Klugar,	Miloslav	(Avtor)
	</dc:creator><dc:subject>cohort studies</dc:subject><dc:subject>cross-sectional studies</dc:subject><dc:subject>COVID-19</dc:subject><dc:subject>drug-related side effects</dc:subject><dc:subject>adverse reactions</dc:subject><dc:subject>health personnel</dc:subject><dc:subject>mass vaccination</dc:subject><dc:subject>prevalence</dc:subject><dc:description>Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.</dc:description><dc:date>2021</dc:date><dc:date>2022-05-10 13:55:31</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>136546</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>